Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 101 publications
YK-4-250 mitigates gastrointestinal radiation syndrome and promotes overall survival following partial body radiation injury.
Journal: Scientific reports
Published: March 31, 2026
DCLK1 regulates stemness and IL-6/STAT3-dependent metastatic niche formation in chemoresistant ovarian cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 30, 2026
Mitophagy-Competent Cancer-Associated Fibroblasts Fuel Chemoresistance by Rewiring Pyrimidine Metabolism in Pancreatic Cancer.
Journal: Cancer research
Published: December 14, 2025
Hepatocyte MLKL Drives Obesity-Driven Hepatocellular Carcinoma Progression via Mitochondrial Dysfunction Independent of Necroptosis in MASLD.
Journal: bioRxiv : the preprint server for biology
Published: December 12, 2025
Correction: MacCuaig et al. Toxicity Assessment of Mesoporous Silica Nanoparticles upon Intravenous Injection in Mice: Implications for Drug Delivery. Pharmaceutics 2022, 14, 969.
Journal: Pharmaceutics
Published: December 11, 2025
Hepatocyte MLKL drives obesity-driven hepatocellular carcinoma progression via mitochondrial dysfunction independent of necroptosis in MASLD.
Journal: Hepatology (Baltimore, Md.)
Published: November 26, 2025
Tumor microenvironment and macroenvironment: A new perspective on holistic oncology.
Journal: Cancer letters
Published: September 17, 2025
Alternatively activated macrophages cause DNA damage through an arginase 1-mediated bystander effect and promote epithelial cell transformation.
Journal: Oncogenesis
Published: September 17, 2025
Tumor-immune-neural circuit disrupts energy homeostasis in cancer cachexia.
Journal: Cancer cell
Published: July 18, 2025
A Non-canonical Role for Hepatocyte MLKL in Promoting Mitochondrial Dysfunction and Senescence in the Aging Liver.
Journal: bioRxiv : the preprint server for biology
Published: July 14, 2025
Corrigendum to "Targeting doublecortin-like kinase 1 reveals a novel strategy to circumvent chemoresistance and metastasis in ovarian cancer" [Cancer Lett. 2023 Dec 1;578:216437].
Journal: Cancer letters
Published: July 03, 2025
Evaluation of Ferroptosis as a Biomarker to Predict Treatment Outcomes of Cancer Immunotherapy.
Journal: Cancer research communications
Published: May 19, 2025
Last Updated: 09/26/2026